Improved tolerability of amifostine with rapid infusion and optimal patient preparation

被引：14

作者：

Boccia, R ^{[1
]}

机构：

[1] Ctr Canc & Blood Disorder, Bethesda, MD 20817 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 06期

关键词：

D O I：

10.1053/sonc.2002.37358

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9 / 13

页数：5

共 26 条

[1] A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer [J].

Anné, PR ;

Curran, WJ .

SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :18-19

[2]

BOCCIA RV, 2002, P AN M AM SOC CLIN, V21, pB269

[3]

BOCCIA RV, 2001, P AN M AM SOC CLIN, V20, pB300

[4] A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma [J].

Bourhis, J ;

De Crevoisier, R ;

Abdulkarim, B ;

Deutsch, E ;

Lusinchi, A ;

Luboinski, B ;

Wibault, P ;

Eschwege, F .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (05) :1105-1108

[5] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J].

Brizel, DM ;

Wasserman, TH ;

Henke, M ;

Strnad, V ;

Rudat, V ;

Monnier, A ;

Eschwege, F ;

Zhang, J ;

Russell, L ;

Oster, W ;

Sauer, R .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) :3339-3345

[6] Radiochemotherapy with amifostine cytoprotection for head and neck cancer [J].

Buntzel, J ;

Schuth, J ;

Kuttner, K ;

Glatzel, M .

SUPPORTIVE CARE IN CANCER, 1998, 6 (02) :155-160

[7] Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer [J].

Buntzel, J ;

Kuttner, K ;

Frohlich, D ;

Glatzel, M .

ANNALS OF ONCOLOGY, 1998, 9 (05) :505-509

[8] Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study [J].

Capelli, D ;

Santini, G ;

De Souza, C ;

Poloni, A ;

Marino, G ;

Montanari, M ;

Lucesole, M ;

Brunori, R ;

Massidda, D ;

Offidani, M ;

Leoni, P ;

Olivieri, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (02) :300-307

[9]

DALY C, 2002, P AN M AM SOC CLIN, V21, pB263

[10] The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors [J].

Hartmann, JT ;

Knop, S ;

Fels, LM ;

van Vangerow, A ;

Stolte, H ;

Kanz, L ;

Bokemeyer, C .

ANTI-CANCER DRUGS, 2000, 11 (01) :1-6

← 1 2 3 →